您的当前位置:首页 > 行业数据 > 中国创新药企在PD-(L)1Plus双抗布局上处于领先地位(续)
图片属性
图片格式:PNG 图片大小:461KB 图片尺寸:2346*1842
同报告图片
 / 4
中国创新药企在PD-(L)1Plus双抗布局上处于领先地位(续)_第1页
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
中国创新药企在PD-(L)1Plus双抗布局上处于领先地位(续)_第2页
中国创新药企在PD-(L)1Plus双抗布局上处于领先地位(续)_第3页
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
中国创新药企在PD-(L)1Plus双抗布局上处于领先地位(续)_第4页
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
中国创新药企在PD-(L)1Plus双抗布局上处于领先地位(续)_第5页
所属报告: 国产抗体行业(一):从跟随到突破PD~(L)1、VEGF正当时-250715(38页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠